While CD11b+ myeloid cells, CD11b+F4/80+ macrophages, and CD11c+ dendritic cells trended toward higher accumulation at week 1 post-tumor cell implantation in the ETBF group, CD11b+F4/80+ macrophages and CD11c+ dendritic cells showed significantly higher accumulation in tumors from ETBF-infected mice at 4 weeks post-tumor implantation (Figure 3B). This evidence concerns the gene ITGAX and neoplasm.